Clinical Characteristics, Presentation, and Outcomes of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH) is increasingly being recognized as a cause of morbidity and mortality in preterm infants. Recently, BPD-PH has also been shown to have additional long-term negative effects on neurodevelopmental outcomes and right ventricular function. Several significant risk factors associated with the development of BPD-PH have been identified. A screening strategy for BPD-PH is needed for infants presenting more than one risk factor. In addition, an early echocardiogram within 14 days of age may be a useful tool to identify infants at high-risk for BPD-PH. We have reviewed recent progress in research concerning clinical characteristics, presentation, and outcomes of BPD-PH and have suggested direction for future studies.
Abstract
Bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH) is increasingly being recognized as a cause of morbidity and mortality in preterm infants. Recently, BPD-PH has also been shown to have additional long-term negative effects on neurodevelopmental outcomes and right ventricular function. Several significant risk factors associated with the development of BPD-PH have been identified. A screening strategy for BPD-PH is needed for infants presenting more than one risk factor. In addition, an early echocardiogram within 14 days of age may be a useful tool to identify infants at high-risk for BPD-PH. We have reviewed recent progress in research concerning clinical characteristics, presentation, and outcomes of BPD-PH and have suggested direction for future studies.
참고문헌 (23)
- Mourani PM, "Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond", Curr Opin Pediatr, 25, pp.329~337 (2013)[DOI]
- 김도현, "기관지폐 형성 이상에 동반된 폐동맥 고혈압의 병태 생리와 위험 인자", Perinatology, 25(1), pp.1~8 (2014), 대한주산의학회
- 안효순, "Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia", Korean Circulation Journal, 40(3), pp.131~136 (2010), 대한심장학회
- Slaughter JL, "Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation", J Perinatol, 31, pp.635~640 (2011)[DOI]
- Kim DH, "Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia", Neonatology, 101, pp.40~46 (2012)[DOI]
- Bhat R, "Prospective analysis of pulmonary hypertension in extremely low birth weight infants", Pediatrics, 129, pp.e682~e689 (2012)[DOI]
- Mourani PM, "Pulmonary hypertension and vascular abnormalities in bronchopulmonary dysplasia", Clin Perinatol, 42, pp.839~855 (2015)[DOI]
- Mourani PM, "Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia", Am J Respir Crit Care Med, 191, pp.87~95 (2015)[DOI]
- Arjaans S, "Identification of gaps in the current knowledge on pulmonary hypertension in extremely preterm infants: a systematic review and meta-analysis", Paediatr Perinat Epidemiol, 32, pp.258~267 (2018)[DOI]
- Khemani E, "Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era", Pediatrics, 120, pp.1260~1269 (2007)[DOI]
- Kumar VH, "Characteristics of pulmonary hypertension in preterm neonates", J Perinatol, 27, pp.214~219 (2007)[DOI]
- Al-Ghanem G, "Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis", J Perinatol, 37, pp.414~419 (2017)[DOI]
- Nakanishi H, "Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study", J Perinatol, 36, pp.890~896 (2016)[DOI]
- Kwon HW, "Long-term outcomes of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia", Neonatology, 110, pp.181~189 (2016)[DOI]
- del Cerro MJ, "Pulmonary hypertension in bronchopulmonary dysplasia: clinical findings, cardiovascular anomalies and outcomes", Pediatr Pulmonol, 49, pp.49~59 (2014)[DOI]
- Abman SH, "Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society", Circulation, 132, pp.2037~2099 (2015)[DOI]
- Nagiub M, "Risk factors for development of pulmonary hypertension in infants with bronchopulmonary dysplasia: systematic review and meta-analysis", Paediatr Respir Rev, 23, pp.27~32 (2017)
- Mirza H, "Pulmonary hypertension in preterm infants: prevalence and association with bronchopulmonary dysplasia", J Pediatr, 165, pp.909~914 (2014)[DOI]
- Berenz A, "Evidence of early pulmonary hypertension is associated with increased mortality in very low birth weight infants", Am J Perinatol, 34, pp.801~807 (2017)[DOI]
- Kim SY, "Pulmonary arterial hypertension after ibuprofen treatment for patent ductus arteriosus in very low birth weight infants", J Pediatr, 179, pp.49~53 (2016)[DOI]
- Kim DH, "Association of increased cord blood soluble endoglin with the development of bronchopulmonary dysplasia in preterm infants with maternal preeclampsia", Pregnancy Hypertens, 13, pp.148~153 (2018)[DOI]
- Kim DH, "Serial changes of serum endostatin and angiopoietin-1 levels in preterm infants with severe bronchopulmonary dysplasia and subsequent pulmonary artery hypertension", Neonatology, 106, pp.55~61 (2014)[DOI]
- Robbins IM, "National Heart, Lung, and Blood Institute Workshop: improving outcomes for pulmonary vascular disease", Circulation, 125, pp.2165~2170 (2012)[DOI]